Intermittent fasting inhibits platelet activation and thrombosis through the intestinal metabolite indole-3-propionate

Abstract

Platelet hyperreactivity contributes significantly to thrombosis in acute myocardial infarction and stroke. While antiplatelet drugs are used, residual ischemic risk remains. Intermittent fasting (IF), a dietary pattern characterized by alternating periods of eating and fasting, has shown cardiovascular benefits, but its effect on platelet activation is unclear. This study demonstrates that IF inhibits platelet activation and thrombosis in both patients with coronary artery disease and apolipoprotein E (ApoE) knockout (ApoE^−/−) mice, by enhancing intestinal flora production of indole-3-propionic acid (IPA). Mechanistically, elevated IPA in plasma directly attenuates platelet activation by binding to the platelet pregnane X receptor (PXR) and suppressing downstream signaling pathways, including Src/Lyn/Syk and LAT/PLCγ/PKC/Ca²⁺. Importantly, IF alleviates myocardial and cerebral ischemia/reperfusion injury in ApoE^−/− mice. These findings suggest that IF mitigates platelet activation and thrombosis risk in coronary atherosclerosis by enhancing intestinal flora production of IPA, which subsequently activates the platelet PXR-related signaling pathways.

Keywords

intermittent fasting / indole-3-propionate / platelet activation / arterial thrombosis / PXR

References

[1] Gurbel PA , Jeong YH , Navarese EP et al. Platelet-mediated thrombosis: from bench to bedside. Circ Res 2016; 118: 1380- 91.

[2] Koenen RR , Binder CJ . Platelets and coagulation factors: established and novel roles in atherosclerosis and atherothrombosis. Atherosclerosis 2020; 307: 78- 9.

[3] Murphy AJ , Tall AR . Disordered haematopoiesis and athero-thrombosis. Eur Heart J 2016; 37: 1113- 21.

[4] Santilli F , Vazzana N , Liani R et al. Platelet activation in obesity and metabolic syndrome. Obes Rev 2012; 13: 27- 42.

[5] Hu L , Chang L , Zhang Y et al. Platelets express activated P2Y₁₂ receptor in patients with diabetes mellitus. Circulation 2017; 136: 817- 33.

[6] Falk E , Nakano M , Bentzon JF et al. Update on acute coronary syndromes: the pathologists’ view. Eur Heart J 2013; 34: 719- 28.

[7] Koupenova M , Kehrel BE , Corkrey HA et al. Thrombosis and platelets: an update. Eur Heart J 2017; 38: 785- 91.

[8] Belkacemi L , Selselet-Attou G , Louchami K et al. Intermittent fasting modulation of the diabetic syndrome in sand rats. Ⅱ. Investigations. Int J Mol Med 2010; 26: 759- 65.

[9] Obermayer A , Tripolt NJ , Pferschy PN et al. Efficacy and safety of intermittent fasting in people with insulin-treated type 2 diabetes (INTERFAST-2): a randomized controlled trial. Diabetes Care 2023; 46: 463- 8.

[10] Bhutani S , Klempel MC , Kroeger CM et al. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity (Silver Spring, Md.) 2013; 21: 1370- 9.

[11] Gallage S , Ali A , Barragan Avila JE et al. A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1. Cell Metab 2024; 36: 1371- 93.e7.

[12] Pan RY , Zhang J , Wang JL et al. Intermittent fasting protects against Alzheimer’s disease in mice by altering metabolism through remodeling of the gut microbiota. Nat Aging 2022; 2: 1024- 39.

[13] Kapogiannis D , Manolopoulos A , Mullins R et al. Brain responses to intermittent fasting and the healthy living diet in older adults. Cell Metab 2024; 36: 1668- 78.e5.

[14] Weir HJ , Yao P , Huynh FK et al. Dietary restriction and AMPK increase lifespan via mitochondrial network and peroxisome remodeling. Cell Metab 2017; 26: 884- 96.e5.

[15] Chair SY , Cai H , Cao X et al. Intermittent fasting in weight loss and cardiometabolic risk reduction: a randomized controlled trial. J Nurs Res 2022; 30: e185.

[16] Wan R , Camandola S , Mattson MP . Intermittent food deprivation improves cardiovascular and neuroendocrine responses to stress in rats. J Nutr 2003; 133: 1921- 9.

[17] Eshghinia S , Mohammadzadeh F . The effects of modified alternate-day fasting diet on weight loss and CAD risk factors in overweight and obese women. J Diabetes Metab Disord. 2013; 12: 4.

[18] Varady KA , Bhutani S , Klempel MC et al. Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial. Nutr J 2013; 12: 146.

[19] Varady KA , Roohk DJ , Loe YC et al. Effects of modified alternateday fasting regimens on adipocyte size, triglyceride metabolism, and plasma adiponectin levels in mice. J Lipid Res 2007; 48: 2212- 9.

[20] Belkacemi L , Selselet-Attou G , Hupkens E et al. Intermittent fasting modulation of the diabetic syndrome in streptozotocininjected rats. Int J Endocrinol. 2012; 2012: 962012.

[21] Chaix A , Zarrinpar A , Miu P et al. Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab 2014; 20: 991- 1005.

[22] Mager DE , Wan RQ , Brown M et al. Caloric restriction and intermittent fasting alter spectral measures of heart rate and blood pressure variability in rats. FASEB J 2006; 20: 631- 7.

[23] Frank J , Gupta A , Osadchiy V et al. Brain-gut-microbiome interactions and intermittent fasting in obesity. Nutrients 2021; 13: 584.

[24] Ozkul C , Yalinay M , Karakan T . Islamic fasting leads to an increased abundance of Akkermansia muciniphila and Bacteroides fragilis group: a preliminary study on intermittent fasting. Turk J Gastroenterol 2019; 30: 1030- 5.

[25] Su JH , Wang YY , Zhang XF et al. Remodeling of the gut microbiome during Ramadan-associated intermittent fasting. Am J Clin Nutr 2021; 113: 1332- 42.

[26] Ozkul C , Yalinay M , Karakan T . Structural changes in gut microbiome after Ramadan fasting: a pilot study. Benef Microbes. 2020; 11: 227- 33.

[27] Guo Y , Luo S , Ye Y et al. Intermittent fasting improves cardiometabolic risk factors and alters gut microbiota in metabolic syndrome patients. J Clin Endocrinol Metab 2021; 106: 64- 79.

[28] Gabel K , Marcell J , Cares K et al. Effect of time restricted feeding on the gut microbiome in adults with obesity: a pilot study. Nutr Health 2020; 26: 79- 85.

[29] Flora GD , Sahli KA , Sasikumar P et al. Non-genomic effects of the pregnane X receptor negatively regulate platelet functions, thrombosis and haemostasis. Sci Rep 2019; 9: 17210.

[30] Venkatesh M , Mukherjee S , Wang HW et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity 2014; 41: 296- 310.

[31] Xue H , Chen X , Yu C et al. Gut microbially produced indole-3-propionic acid inhibits atherosclerosis by promoting reverse cholesterol transport and its deficiency is causally related to atherosclerotic cardiovascular disease. Circ Res 2022; 131: 404- 20.

[32] Li Z , Delaney MK , O’Brien KA et al. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 2010; 30: 2341- 9.

[33] Shen B , Zhao X , O’Brien KA et al. A directional switch of integrin signalling and a new anti-thrombotic strategy. Nature 2013; 503: 131- 5.

[34] Zhang LS , Davies SS . Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med 2016; 8: 46.

[35] Köhler D , Granja T , Volz J et al. Red blood cell-derived semaphorin 7A promotes thrombo-inflammation in myocardial ischemia-reperfusion injury through platelet GPIb. Nat Commun 2020; 11: 1315.

[36] Sutton EF , Beyl R , Early KS et al. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab 2018; 27: 1212- 21.e3.

[37] Johnson JB , Summer W , Cutler RG et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Rad Biol Med 2007; 42: 665- 74.

[38] Allaf M , Elghazaly H , Mohamed OG et al. Intermittent fasting for the prevention of cardiovascular disease. Cochrane Database Syst Rev 2021; 1: CD013496.

[39] American Heart Association . 8-hour time-restricted eating linked to a 91% higher risk of cardiovascular death. ScienceDaily Retrieved April 2024; 16: 2024.

[40] Deng YJ , Yang XY , Ye XR et al. Alternate day fasting aggravates atherosclerosis through the suppression of hepatic ATF3 in Apoe^−/− mice. Life Metab. 2024; 3: loae009.

[41] Serger E , Luengo-Gutierrez L , Chadwick JS et al. The gut metabolite indole-3 propionate promotes nerve regeneration and repair. Nature 2022; 607: 585- 92.

[42] Dodd D , Spitzer MH , Van Treuren W et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 2017; 551: 648- 52.

[43] Elsden SR , Hilton MG , Waller JM . The end products of the metabolism of aromatic amino acids by Clostridia. Arch Microbiol 1976; 107: 283- 8.

[44] Wikoff WR , Anfora AT , Liu J et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 2009; 106: 3698- 703.

[45] Williams BB , Van Benschoten AH , Cimermancic P et al. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe 2014; 16: 495- 503.

[46] Zhu WF , Gregory JC , Org E et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 2016; 165: 111- 24.

[47] Nemet I , Saha PP , Gupta N et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell 2020; 180: 862- 77.e22.

[48] Venu VKP , Saifeddine M , Mihara K et al. The pregnane X receptor and its microbiota-derived ligand indole 3-propionic acid regulate endothelium-dependent vasodilation. Am J Physiol-Endoc M 2019; 317: E350- 61.

[49] Flannigan KL , Nieves KM , Szczepanski HE et al. The pregnane X receptor and indole-3-propionic acid shape the intestinal mesenchyme to restrain inflammation and fibrosis. Cell Mol Gastroenterol Hepatol 2023; 15: 765- 95.

[50] Li Q , You YR , Zeng YP et al. Associations between plasma tryptophan and indole-3-propionic acid levels and mortality in patients with coronary artery disease. Am J Clin Nutr 2022; 116: 1070- 7.

[51] Zhang YQ , Li SS , Fan XJ et al. Pretreatment with indole-3-propionic acid attenuates lipopolysaccharide-induced cardiac dysfunction and inflammation through the AhR/NF-κB/NLRP3 pathway. J Inflamm Res. 2024; 17: 5293- 309.

[52] Ho KJ , Ramirez JL , Kulkarni R et al. Plasma gut microbe-derived metabolites associated with peripheral artery disease and major adverse cardiac events. Microorganisms 2022; 10: 2065.

[53] Gotru SK , Mammadova-Bach E , Sogkas G et al. MAGT1 deficiency dysregulates platelet cation homeostasis and accelerates arterial thrombosis and ischemic stroke in mice. Arterioscler Thromb Vasc Biol 2023; 43: 1494- 509.

[54] Wang RN , Xiao L , Pan JB et al. Natural product P57 induces hypothermia through targeting pyridoxal kinase. Nat Commun 2023; 14: 5984.

[55] Zeng XZ , Li J , Shan WR et al. Gut microbiota of old mice worsens neurological outcome after brain ischemia via increased valeric acid and IL-17 in the blood. Microbiome 2023; 11: 204.

[56] Qi Z , Hu L , Zhang J et al. PCSK9 (proprotein convertase subtilisin/ kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36. Circulation 2021; 143: 45- 61.

[57] Chen Y , Hong J , Zhong H et al. IL-37 attenuates platelet activation and thrombosis through IL-1R8 pathway. Circ Res 2023; 132: e134- 50.

[58] Chen Y , Fu W , Zheng Y et al. Galectin 3 enhances platelet aggregation and thrombosis via Dectin-1 activation: a translational study. Eur Heart J 2022; 43: 3556- 74.

RIGHTS & PERMISSIONS

The Author(s). Published by Oxford University Press on behalf of Higher Education Press.